These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29309347)

  • 21. [Simplification of the antiretroviral regimens. A need to guarantee the long-term control of HIV infection].
    Barreiro García P; Soriano Vázquez V
    Rev Clin Esp; 2004 Apr; 204(4):212-4. PubMed ID: 15104931
    [No Abstract]   [Full Text] [Related]  

  • 22. "High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART.
    Lanzafame M; Piacentini D; Lattuada E; Rizzardo S; Chiesi S; Vento S
    Infect Dis (Lond); 2018 Oct; 50(10):788-790. PubMed ID: 29916752
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiretroviral reduction: is it time to rethink the unthinkable?
    Colasanti J; Marconi VC; Taiwo B
    AIDS; 2014 Apr; 28(7):943-7. PubMed ID: 24401641
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.
    Townsend CL; Willey BA; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2009 Feb; 23(4):519-24. PubMed ID: 19165088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons from the 11th conference on retroviruses and opportunistic infections.
    Laurence J
    AIDS Read; 2004 Apr; 14(4):151-3. PubMed ID: 15116693
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeting JNK to prevent antiretroviral neuropathy.
    Galeotti N
    Oncotarget; 2017 Feb; 8(8):12546-12547. PubMed ID: 28179580
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxicities of antiretroviral therapy in children.
    Nwaobasi E; Oleske JM
    AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
    Morelle J; Goffin E; Wallemacq P; De Meyer M; Yombi JC; Mourad M; Kanaan N
    Transpl Int; 2010 Oct; 23(10):1065-7. PubMed ID: 20477995
    [No Abstract]   [Full Text] [Related]  

  • 29. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
    Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
    HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 31. Ask the experts.
    Kaiser JD
    Explore (NY); 2006; 2(5):471-2. PubMed ID: 16979115
    [No Abstract]   [Full Text] [Related]  

  • 32. The long-term consequences of antiretroviral therapy.
    Smith D
    J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
    [No Abstract]   [Full Text] [Related]  

  • 33. New antiretroviral drugs and approaches to HIV treatment.
    Paredes R; Clotet B
    AIDS; 2003; 17 Suppl 4():S85-96. PubMed ID: 15080184
    [No Abstract]   [Full Text] [Related]  

  • 34. Monitoring of long-term toxicities of HIV treatments: an international perspective.
    Bisson G; Gross R; Miller V; Weller I; Walker A; Arlett P; Carr A; Evans S; Graham D; Justice A; Kreft-Jais C; Lundgren JD; Munk B; Murray J; Pirmohamed M; Pizzuti D; Szarfman A;
    AIDS; 2003 Nov; 17(17):2407-17. PubMed ID: 14600511
    [No Abstract]   [Full Text] [Related]  

  • 35. Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs.
    Mercuro G; Cadeddu C; Nocco S; Deidda M; Mercuro S; Piano P; Ortu F; Manconi PE
    Int J Cardiol; 2013 Sep; 168(2):1538-9. PubMed ID: 23287696
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management.
    Manfredi R
    AIDS; 2003 Oct; 17(15):2253-6. PubMed ID: 14523283
    [No Abstract]   [Full Text] [Related]  

  • 37. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment interruption in HIV therapy: a SMART strategy?
    Jülg B; Goebel FD
    Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 30-year-old man with HIV infection and fever with cough 2 months after starting antiretroviral therapy.
    Xhani D; Hage CA; Knox KS
    Chest; 2007 Jul; 132(1):354-7. PubMed ID: 17625099
    [No Abstract]   [Full Text] [Related]  

  • 40. Initial antiretroviral therapy regimen and risk of heart failure: Erratum.
    AIDS; 2024 Aug; 38(10):1608. PubMed ID: 38990320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.